Pacira Completes Acquisition of MyoScience, Advancing Leadership in Non-opioid Pain Management with FDA-approved ioveraº System
Pacira BioSciences, Inc. ("Pacira") (NASDAQ:PCRX)...
Read MorePacira BioSciences, Inc. ("Pacira") (NASDAQ:PCRX)...
Read MoreInovio Pharmaceuticals, Inc. (NASDAQ: INO)...
Read MoreIn a new series of...
Read MoreOncolytics Biotech® Inc. ONCY, +2.42%...
Read MoreWuXi Biologics ("WuXi Bio") (2269.HK),...
Read MoreThe biomolecule ribonucleic acid (RNA)...
Read MoreThe U.S. Food and Drug...
Read MoreXcell Biosciences Corporation, a provider...
Read MoreSyngene International Limited, a leading...
Read MorePfizer PFE, +0.58% today announced...
Read More